Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Elm

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Epilepsy & Behavior : E&B|January 7, 2023
Why ketamineLisa Coles, Eric S Rosenthal, Thomas P Bleck, et al.
Stroke|February 21, 2020
Disability After Minor Stroke and Transient Ischemic Attack in the POINT TrialBrett Cucchiara, Jordan Elm, J Donald Easton, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Using global statistical tests in long-term Parkinson's disease clinical trialsPeng Huang, Christopher G Goetz, Robert F Woolson, et al.
Journal of Parkinson'S Disease|October 15, 2014
Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating ScaleSotirios A Parashos, Jordan Elm, James T Boyd, et al.
Journal of the American Heart Association|February 3, 2026
General Anesthesia Versus Conscious Sedation for Mechanical Thrombectomy in Patients With Acute Ischemic Stroke in the MOST TrialUmeshkumar Athiraman, Akash Roy, Andrew Barreto, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 10, 2020
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methodsS Iris Deeds, Andrew Barreto, Jordan Elm, et al.
Frontiers in Neurology|August 9, 2023
Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacyDaniel H Lench, Travis H Turner, Colin McLeod, et al.
Contemporary Clinical Trials Communications|December 17, 2024
TEleRehabilitation foR Aphasia (TERRA) phase II trial designChristy Cassarly, Alexandra Basilakos, Lisa Johnson, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Brain Communications|August 23, 2021
Individualized response to semantic versus phonological aphasia therapies in strokeSigfus Kristinsson, Alexandra Basilakos, Jordan Elm, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Epilepsy & Behavior : E&B|January 7, 2023
Why ketamineLisa Coles, Eric S Rosenthal, Thomas P Bleck, et al.
Stroke|February 21, 2020
Disability After Minor Stroke and Transient Ischemic Attack in the POINT TrialBrett Cucchiara, Jordan Elm, J Donald Easton, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 11, 2009
Using global statistical tests in long-term Parkinson's disease clinical trialsPeng Huang, Christopher G Goetz, Robert F Woolson, et al.
Journal of Parkinson'S Disease|October 15, 2014
Validation of an ambulatory capacity measure in Parkinson disease: a construct derived from the Unified Parkinson's Disease Rating ScaleSotirios A Parashos, Jordan Elm, James T Boyd, et al.
Journal of the American Heart Association|February 3, 2026
General Anesthesia Versus Conscious Sedation for Mechanical Thrombectomy in Patients With Acute Ischemic Stroke in the MOST TrialUmeshkumar Athiraman, Akash Roy, Andrew Barreto, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 10, 2020
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methodsS Iris Deeds, Andrew Barreto, Jordan Elm, et al.
Frontiers in Neurology|August 9, 2023
Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacyDaniel H Lench, Travis H Turner, Colin McLeod, et al.
Contemporary Clinical Trials Communications|December 17, 2024
TEleRehabilitation foR Aphasia (TERRA) phase II trial designChristy Cassarly, Alexandra Basilakos, Lisa Johnson, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and designS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Brain Communications|August 23, 2021
Individualized response to semantic versus phonological aphasia therapies in strokeSigfus Kristinsson, Alexandra Basilakos, Jordan Elm, et al.
Pageof 5